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Walking the Interactome
for Prioritization of Candidate Disease Genes
Sebastian Ko¨hler,1,2 Sebastian Bauer,1,2 Denise Horn,1 and Peter N. Robinson1,*
The identiﬁcation of genes associated with hereditary disorders has contributed to improvingmedical care and to a better understanding
of gene functions, interactions, and pathways. However, there are well over 1500 Mendelian disorders whose molecular basis remains
unknown. At present, methods such as linkage analysis can identify the chromosomal region in which unknown disease genes are lo-
cated, but the regions could contain up to hundreds of candidate genes. In this work, we present a method for prioritization of candidate
genes by use of a global network distance measure, random walk analysis, for deﬁnition of similarities in protein-protein interaction
networks. We tested our method on 110 disease-gene families with a total of 783 genes and achieved an area under the ROC curve of
up to 98% on simulated linkage intervals of 100 genes surrounding the disease gene, signiﬁcantly outperforming previous methods
based on local distance measures. Our results not only provide an improved tool for positional-cloning projects but also add weight
to the assumption that phenotypically similar diseases are associated with disturbances of subnetworks within the larger protein inter-
actome that extend beyond the disease proteins themselves.Introduction
At the time of this writing, over 1500 Mendelian condi-
tions whose molecular cause is unknown are listed in the
Online Mendelian Inheritance in Man (OMIM) database.1
Additionally, almost all medical conditions are in some
way inﬂuenced by human genetic variation. The identiﬁca-
tion of genes associated with these conditions is a goal of
numerous research groups, in order to both improve med-
ical care and better understand gene functions, interac-
tions, and pathways.2 Most current efforts at disease-gene
identiﬁcation involving linkage analysis or association
studies result in a genomic interval of 0.5–10 cM contain-
ing up to 300 genes.3,4 Sequencing large numbers of candi-
date genes remains a time-consuming and expensive task,
and it is often not possible to identify the correct disease
gene by inspection of the list of genes within the interval.
A number of computational approaches toward candi-
date-gene prioritizationhave been developed that are based
on functional annotation, gene-expression data, or se-
quence-based features.5–14 Recent high-throughput tech-
nologies have produced vast amounts of protein-protein
interaction data,15 which represent a valuable resource
for candidate-gene prioritization, because genes related
to a speciﬁc or similar disease phenotype tend to be located
in a speciﬁc neighborhood in the protein-protein interac-
tionnetwork.16However, todate, relatively simplemethods
for exploring biological networks have been applied to
the problem of candidate-gene prioritization, including
the search for direct neighbors of other disease genes17
and the calculationof the shortest path between candidates
and known disease proteins.11,18
In this work, we have investigated the hypothesis that
global network-similarity measures are better suited toThecapture relationships between disease proteins than are
algorithms based on direct interactions or shortest paths
between disease genes. We have deﬁned 110 disease-gene
families comprising genetically heterogeneous disorders,
cancer syndromes, and complex (polygenic) diseases, and
we have constructed an interaction network based on a
total of 258,314 experimentally veriﬁed or predicted
protein-protein interactions. We demonstrate that random
walk and the related diffusion-kernel method—both of
which capture global relationships within an interaction
network—are greatly superior to local distance measures
within the interaction network and also outperform other
previously published methods. We have made our algo-
rithm freely available on the web, and we also provide pre-
dictions for 287 loci from 80 of the disease-gene families
described in this work.
Material and Methods
Disease-Gene Families
A total of 110 disease-gene families were deﬁned, on the basis of
entries in the OnlineMendelian Inheritance inMan (OMIM) data-
base,1 for genetically heterogeneous disorders in which mutations
in distinct genes are associated with similar or even indistinguish-
able phenotypes; cancer syndromes comprising genes associated
with hereditary cancer, increased risk, or somatic mutation in a
given cancer type; and complex (polygenic) disorders that
are known to be inﬂuenced by variation in multiple genes. Addi-
tionally, we used domain knowledge and literature or database
searches to select all genes clearly associated with the disorder at
hand. The 110 families contained a total of 783 genes with 665 dis-
tinct genes (Some genes were members of more than one disease
family), whereby the largest family contained 41 genes and the
smallest only three genes. On average, each family contained
seven genes. A complete listing of the disease-gene families with1Institute for Medical Genetics, Charite´ Universita¨tsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
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links to the corresponding entries in the OMIM database is given
as Table S1, available online.
Protein-Protein Interaction Data
The protein-protein interaction (PPI) network is represented by an
undirected graphwith nodes representing the genes and edges rep-
resenting the mapped interactions of the proteins encoded by the
genes. To construct the network, ﬁve protein-protein interaction
datasets from human,Mus musculus, Drosophila melanogaster, Cae-
norhabditis elegans, and Saccharomyces cerevisiae were downloaded
from Entrez Gene19 on the 1st of July 2007. These datasets com-
prise interactions extracted from HPRD,20 BIND,21 and BioGrid22.
Additional interactions were extracted from IntACT,23 and DIP.24
Protein interactions were mapped to the genes coding for the pro-
teins, and redundant interactions stemming from multiple data
sources were removed. Interactions from the four nonhuman spe-
cies were mapped to homologous human genes identiﬁed by In-
paranoid25 analysis with a threshold Inparalog score of 0.8. If
both interaction partners could be mapped to human proteins,
the interaction was used.
We also used data from STRING,26 which is a comprehensive
dataset containing functional links between proteins on the basis
of both experimental evidence for protein-protein interactions as
well as interactions predicted by comparative genomics and text
mining. STRING uses a scoring system that is intended to reﬂect
the evidence of predicted interactions. For the present study, we
included interactions with a score of at least 0.4, which corre-
sponds to a medium-conﬁdence network27 (Table 1).
Disease-Gene Prediction
The general idea of the approach is depicted in Figure 1. The details
of how the ranks were obtained are given below.
Random Walk
The random walk on graphs28 is deﬁned as an iterative walker’s
transition from its current node to a randomly selected neighbor
starting at a given source node, s. Here, we used a variant of the
random walk in which we additionally allow the restart of the
walk in every time step at node s with probability r. Formally,
the random walk with restart is deﬁned as:
ptþ1 ¼ ð1 rÞWpt þ rp0
whereW is the column-normalized adjacency matrix of the graph
and pt is a vector in which the i-th element holds the probability
of being at node i at time step t.
In our application, the initial probability vector p0 was con-
structed such that equal probabilities were assigned to the nodes
representingmembers of the disease, with the sum of the probabil-
ities equal to 1. This is equivalent to letting the random walker
begin from each of the known disease genes with equal probabil-
ity. Candidate genes were ranked according to the values in the
steady-state probability vector pN. This was obtained at query
time by performing the iteration until the change between pt
and ptþ1 (measured by the L1 norm) fell below 10
6.
Diffusion Kernel
The diffusion kernel K of a graph G is deﬁned as K ¼ ebL, where,
intuitively, b controls the magnitude of the diffusion. The matrix
L is the Laplacian of the graph, deﬁned as D  A, where A is the
adjacency matrix of the interaction graph andD is a diagonal ma-
trix containing the nodes’ degrees.29 With the use of K, the rank950 The American Journal of Human Genetics 82, 949–958, April 20for each candidate gene jwas assigned in accordance with its score
deﬁned as
scoreðjÞ ¼
X
i˛disease gene family
Kij
For a sufﬁcient small b the diffusion kernel can be seen as a lazy
randomwalk consisting of transitions to one of each of the current
node’s neighbors with probability of b, whereby the walker re-
mains at the current node i with a probability of 1  dib (with di
being the degree of node i). The column vector j of the matrix K
then represents the steady-state probability vector of the random
walk when starting at node j.
Other Methods
For comparison with previously published methods, we have im-
plemented screens of candidate genes in a linkage interval for di-
rect interactions (DI) with other known disease-family proteins,17
whereby genes are predicted as potential disease genes if they have
a direct interaction to known disease genes. We implemented
a ranking of candidate genes according to the single shortest
path (SP) to any known disease protein in the family (comparable
to the CPS method in 18).
Furthermore, we ranked the genes in our test set with PROS-
PECTR, which uses a variety of sequence-based features, such as
gene length, to train an alternating decision tree to rank genes
in the order of likelihood of involvement in disease.13 Addition-
ally, the internet implementation of ENDEAVOUR10 was used to
test the genes listed in Table 2.
Performance Measurement
For each disease gene we deﬁned the artiﬁcial linkage interval to
be the set of genes containing the ﬁrst 100 genes located nearest
to the disease gene according to their genomic distance on the
same chromosome. In order to measure the performance of the
whole optimization and training procedure, leave-one-out cross-
validation was used for each disease-gene family. If a ranking
method gives the actual disease gene the highest ranking and it
is sequenced ﬁrst, there is an enrichment of 50-fold. In general,
the formula is Enrichment¼ 50/(rank) for an interval of 100 genes.
For the present analysis, disease genes for which no interaction
Table 1. Networks Tested in this Work
Network
Number of
Interactors
Number of
Interactions
Human 9169 35,910
Mapped:
Worm 684 (146) 831 (768)
Mouse 1412 (78) 1972 (853)
Fruitfly 2176 (590) 4930 (4,613)
Yeast 1557 (441) 33,396 (32,855)
Total Human and Mapped 10,231 74,885
STRING 12,594 209,089
All Data Sources 13,726 258,314
All Data Sources Excluding
Text-Mining Data
11,673 133,612
‘‘Mapped’’ indicates protein-protein interaction data mapped to orthologous
human proteins. The number of new interactors/interactions that were
added to the interaction network by mapping is shown in parentheses.
‘‘All Data Sources’’ denotes the STRING data, human, and mapped interac-
tions.08
Figure 1. Disease-Gene Prioritization
(A) All candidate genes contained in the linkage interval are mapped to the interaction network, as are all previously known disease genes
of the family in question. Our method then assigns a score to each of the candidate genes, with investigation of the relative location of
the candidate to all of the known ‘‘disease genes’’ by the use of global network-distance measures. The genes in the linkage interval are
ranked according to the score in order to define a priority list of candidates for further biological investigation.
(B–D) Each of the three subnetworks displays a different configuration consisting of the same number of nodes. The global distance be-
tween a hypothetical disease gene (x) and a candidate gene (y) is different in each case. In (B), proteins x and y are connected via a hub
node with many other connections, so that the global similarity (sxy) is less than in (C), where x and y are connected by a protein with
fewer connections than those of the hub. On the other hand, nodes that are connected by multiple paths (D) receive a higher similarity
than do nodes connected by only one path. Note that the shortest path between x and y is identical in each case (B–D), so that distance
measures relying on such local information cannot differentiate between these three types of connection. In particular, the approach
taking only direct interactions with gene x into account would identify gene y as a candidate in none of the three cases.data were available were given a rank of 100 (and therefore an
enrichment score of 0.5). No correction was made for intervals
withinwhich some proteins had no interaction data. If a particular
method assigns an identical score to more than one gene, we as-
sume the worst case, in which the true disease gene is the last to
be sequenced from the set of equally ranked genes.
Another measure of performance of the algorithm is the
receiver-operating characteristic (ROC) analysis, which plots the
true-positive rate (TPR) versus the false-positive rate (FPR) subject
to the threshold separating the prediction classes. The TPR/FPR
is the rate of correctly/incorrectly classiﬁed samples of all samples
classiﬁed to class þ1. For evaluating rankings of disease-gene pre-
dictions, ROC values can be interpreted as a plot of the frequency
of the disease genes above the threshold versus the frequency of
disease genes below the threshold, where the threshold is a speciﬁc
position in the ranking.10 In order to compare different curves ob-
tained by ROC analysis, we calculate the area under the ROC curve
(AUROC) for each curve.
Results
In this work, we constructed an interaction network based
on a total of 35,910 interactions between human proteinsTheas well as 38,975 mapped interactions from four other spe-
cies. Additionally predicted protein interactions from the
STRINGdatabase26were used (Table 1).We adapted a global
distance measure based on random walk with restart
(RWR) to deﬁne similarity between genes within this inter-
action network and to rank candidates on the basis of this
similarity to known diseases genes. Intuitively, the RWR
algorithm calculates the similarity between two genes, i
and j, on the basis of the likelihood that a random walk
through the interaction network starting at gene i will
ﬁnish at gene j, whereby all possible paths between the
two genes are taken into account. In our implementation,
we let the random walk start with equal probability from
each of the known disease-gene family members in order
to search for an additional family member in the linkage
interval (Figure 1). For comparison, we also implemented
a similar global search algorithm based on the diffusion
kernel (DK), which conceptually performs a different
type of random walk calculated by matrix exponentiation
(see Material and Methods for mathematical details). In
order to compare the performance of global and local net-
work search algorithms, we implemented two previousAmerican Journal of Human Genetics 82, 949–958, April 2008 951
methods based on searching for disease genes among
direct-interaction partners of candidate genes and search-
ing for the single shortest path to a known disease gene,
and we also utilized PROSPECTR, a previously described
sequence-based ranking system.13 We tested our method
on 86 genetically heterogeneous disorders in which muta-
tions in distinct genes are associated with similar or even
indistinguishable phenotypes; 12 cancer syndromes com-
prising genes associated with hereditary cancer, increased
risk, or somatic mutation in a given cancer type; and 12
complex (polygenic) disorders that are known to be inﬂu-
enced by variation in multiple genes. For every such fam-
ily, we then performed leave-one-out cross-validation (see
Material and Methods).
Using the network containing all interactions (including
text-mining data) and the RWR technique, we ranked
all genes of 43 disease-gene families ﬁrst (50-fold enrich-
ment). For instance, all genes of Hirschsprung disease
(six genes), Waardenburg syndrome (six genes), adrenoleu-
kodystrophy (ﬁve genes), and limb-girdle muscular dystro-
phy (14 genes) families were ranked ﬁrst. On average, we
achieved an enrichment score of 44-fold for all 783 disease
genes using all data sources including the text-mining
component of STRING. Similar but slightly inferior results
were obtained for the other global searchmethod based on
the DK. Leaving out text mining data, the RWR achieved
a mean enrichment of 27-fold for all 110 disease families.
The best results were obtained for families of heteroge-
neous monogenic diseases. However, there was an espe-
cially clear advantage for the RWR and DK methods
Table 2. Performance of Five Candidate-Gene-Prioritization
Methods on Seven Recently Identified Monogenic Disease
Genes
Family Gene
Rankings
Random
Walk ENDEAVOUR SP DI SQ
Nephronophthisis GLIS237 100 43 100 100 3*
ARVD JUP38 1* 1* 1* 2 67
RP TOPORS39 23 69 20* 100 56
RP NR2E340 2 2 18 100 1*
Noonan Syndrome RAF141 1* 3 4 4 42
Brachydactyly NOG42 1* 5 1* 1* 34
CMT4H FGD443 13 2* 27 100 9
Mean Enrichment 25.9* 18.4 17.2 12.8 10.9
Results of random walk, two local network algorithms, ENDEAVOUR,10 and
the sequence analysis program PROSPECTR12 for the prediction of recently
published genes causing monogenic diseases within artificial linkage inter-
vals containing 100 genes.
‘‘SP’’ denotes ranking according to shortest path.
‘‘DI’’ denotes ranking according to direct interaction with a known disease
protein.
‘‘SQ’’ denotes ranking by sequence analysis with PROSPECTR.
‘‘ARVD’’ denotes arrhythmogenic right ventricular dysplasia.
‘‘RP’’ denotes retinitis pigmentosa.
‘‘CMT4H’’ denotes Charcot-Marie-Tooth type 4H.
* indicates best performance.952 The American Journal of Human Genetics 82, 949–958, April 20for polygenic disorders and cancer families compared to
the other methods, although the overall performance of
all methods was somewhat less than with the monogenic
disorders (Figure 2A).
The above comparison (Figure 2A) was performed by as-
sumption of the worst case for genes with equal scores, i.e.,
that the true disease gene is sequenced last among the set
of equally ranked genes. In the complete network (without
text-mining data), genes have an average of 22.9 direct
neighbors. There is a mean path length of 3.7 between ran-
dom pairs of genes. Therefore, there are a lot of direct inter-
actions, and nodes are rarely far apart in the interactome.
One consequence of this for methods such as DI and SP
is that it is not very unlikely to observe interactions that
are unrelated to the disease gene family. In 61% of the cases
in which the DI method correctly identiﬁed the true dis-
ease gene, it additionally identiﬁed other unrelated genes
with a direct interaction to a known disease gene. On the
other hand, in only 1.4% of the cases in which the true dis-
ease gene was ranked in ﬁrst place by the RWRmethod was
another, unrelated gene also given the same score. There-
fore, the RWRmethod is better able to discriminate among
genes within a dense network of interactions. However,
even if all genes with equal scores are assigned the mean
rank, our method clearly outperforms the methods based
on local distance measures (Figure 2B).
We additionally used ROC analysis to compare the vari-
ous methods shown in Figure 2A, conﬁrming the perfor-
mance advantage of RWR and DK analysis compared to
the local interaction screens (DI, SP) and a sequence-based
analysis (Figure 3A).
We then used ROC analysis to compare the performance
of RWR using interaction networks constructed from
several different data sources. Because the different data
sources cover different numbers of genes, we included
only those genes for which interaction data was available
in the ROC analysis (768 of 783 genes for all data sources,
720 of 783 genes for all data sources except text mining,
748 of 783 genes for the STRINGnetwork, 669 of 783 genes
for the human and mapped data, and 664 of 783 genes for
the human data).
Present estimates suggest that only about 10% of all hu-
man protein-protein interactions have been described.30
The choice of data source to use for proteome analyses
essentially amounts to a choice between coverage and ac-
curacy. Protein-protein interactions are often evolution-
arily conserved,31 suggesting the mapping of interactions
between orthologous proteins in other organisms to the
human interactome. Additionally, text mining has been
used as one of the components of STRING to predict pro-
tein-protein interactions.27 Although these computational
techniques increase the coverage of proteins and interac-
tions, they presumably come at the cost of reducing the
overall accuracy of the data by introducing false-positive
interactions. Mapping interactions from four other species
increased the number of genes included in the human PPI
network by over 1000 additional genes (cf. Table 1). The08
Figure 2. Cross-Validation Results
Enrichment analyses for the all-interactions network without STRING text-mining data are shown. Genes within an artificial linkage in-
terval containing 100 genes were ranked according to the methods indicated. The mean enrichment reflects the position of the true dis-
ease gene in the prioritized list and is thereby related to the amount of time saved by the sequencing of candidate genes in the order
calculated by the respective algorithm (see Material and Methods). Two different methods for evaluating genes with equal scores were
evaluated.
(A) If multiple genes receive the same score, the worst case is assumed whereby the true disease gene is the last to be sequenced.
(B) If multiple genes receive the same score, each gene is given the mean rank of all tied genes. The complete list of results for each
disease-gene family is available in Table S2.performance of this mapped network was only slightly
inferior to the network with only human data used, but
given the higher coverage it could be preferable for search-
ing for novel disease genes (Figure 3B). The network with
only medium-conﬁdence STRING data used showed the
best performance of all networks, but fewer genes are
covered in this network than in the complete network
(cf. Table 1).
The highest area under the ROC curve (AUROC) was
98% with text mining and 91% without (Figure 3B). The
improved performance of the network including literature
data conﬁrms previous observations10 that testing gene-
prioritization methods on known disease genes might
introduce a bias because a given gene is likely to be inten-
sively studied in the years following its identiﬁcation as a
human disease gene. This ‘‘previous-knowledge bias’’
means that methods relying on text mining or targeted
experimental studies on individual genesmay perform bet-
ter on historical training data (such as the 110 disease-gene
families described above) than in a prospective setting in
which novel disease genes are sought.
In order to simulate the real-life search for an unknown
novel disease gene, we therefore chose seven disease genes
that were discovered in 2007 and belong to some of the
families investigated in this work. The identiﬁcation ofThethe disease associations of these genes was published sub-
sequent to the creation date of the STRING database we
used, so that we expect minimal publication bias. We
tested these seven genes as above and also tested the per-
formance of ENDEAVOR,10 which has outperformed all
other previously published methods. RWR achieved a
mean enrichment of 26-fold, which was superior to the
results of all other methods (Table 2).
Figures 4 and 5 display the interaction networks associ-
ated with two disease-gene families for which the RWR
ranked each disease gene (red) in ﬁrst place. For compari-
son, unrelated genes that mistakenly receive the highest
rank by the SP method are shown in yellow. For the pro-
tein-interaction network associated with bare lymphocyte
syndrome type 1 (Figure 4), it is apparent that the disease
genes are connected to one another by multiple paths,
comparable to Figure 1D, whereas the unrelated genes
are connected to the true disease genes by single paths
only. As noted above, current databases of human protein
interactions are far from complete. This is clearly problem-
atic for predictions based upon direct interactions with dis-
ease genes, because a lack of direct interactions to disease
genes will automatically result in a false-negative predic-
tion. On the other hand, our method appears to be more
tolerant of incomplete data. For instance, the disease-geneAmerican Journal of Human Genetics 82, 949–958, April 2008 953
Figure 3. Cross-Validation Results
Rank ROC curves were generated for the 110 disease-gene families described in this work. The methods used to calculate the individual
ROC curves are indicated in the figure. Intuitively, the area under the ROC curve (AUROC) reflects the false-positive rate needed to achieve
various levels of sensitivity, with a perfect classifier having an AUROC of 100% and a random classifier having an AUROC of 50%. For
comparison, we excluded disease genes with no interaction data, which were 15 genes in the all-data-sources network, 63 genes in
the same network without text-mining data, 35 genes in the STRING network, 114 with the human and mapped data, and 139 in the
human network.
(A) Comparison of different methods for the all-interactions network without STRING text-mining data. The curve labeled ‘‘random order’’
displays the results obtained by the sequencing of genes within the linkage interval at random, i.e., without use of any prioritization
method.
(B) Comparison of different data sources with RWR analysis.family for Stickler syndrome comprises COL2A1, COL9A1,
COLA11, and COL11A2. Collagen XI is a heterotrimeric
molecule consisting of alpha 1, alpha 2, and alpha 3 colla-
gen chains; in cartilage, it assembles with collagens II and
IX to produce an extensive network of thin, heterotypic
collagen ﬁbrils.32 However, these interactions are not cur-
rently listed in the protein-interaction databases used for
our study. Nonetheless, the RWRmethod made the correct
predictions on the basis of a dense network of other inter-
acting proteins between the disease genes (again compara-
ble to Figure 1D). On the other hand, the unrelated genes
that mistakenly receive the highest rank by the SP method
themselves have numerous other interaction partners, so
that a single path to a single true disease gene is not
weighted highly by the RWR method (Figure 5).
Discussion
Several approaches have been published for the prioritiza-
tion of candidate disease genes, which included functional
as well as sequence-basedmethods. However, the emerging
amounts of protein-protein interaction data have only954 The American Journal of Human Genetics 82, 949–958, April 20sparsely been used for this problem, by investigation of
either the direct interactions to other disease genes10,17,33
or the shortest-path distance to known disease genes.18
In this work, we have presented a novel method for
candidate-gene prioritization based on the random walk
method, which we use to calculate a score reﬂecting the
global similarity of candidate genes to known members
of a disease-gene family (Figure 1).
There are a number of issues to consider when compar-
ing the results of different methods for computational
disease-gene prediction or prioritization. Given the cost
and effort involved in characterizing novel disease genes,
prospective comparisons on large numbers of disease loci
have not been performed. Therefore, most groups have
measured the performance of their algorithms by using
collections of known disease genes. That is, a disease-
gene family is deﬁned, and the method is tested on each
of the members of the family in turn by use of the remain-
ing members of the family as positive examples. In this
context, we feel it is important to create a realistic test
scenario. We have deﬁned artiﬁcial linkage intervals
containing 100 genes around each of the disease genes
being tested in order to simulate the situation facing08
Figure 4. Bare Lymphocyte Syndrome Type 1 Protein-Interaction Network
The protein-interaction network associated with bare lymphocyte syndrome type 1, which comprises the genes TAP1, TAP2, and TAPBP.
Each of these genes is shown in red. The DI and SP methods additionally identified the unrelated genes PSMB8 and PSMB9 (shown in
yellow) as potential disease genes because they each have an interaction with one of the true disease genes. The RWR method ranks
the true disease genes higher because each true disease gene has interactions with two other family members and because there is a dense
net of proteins that connect the disease genes via paths with two interactions. All proteins connected to the correct or incorrect can-
didates by a single interaction are additionally displayed. The graphic was generated with Cytoscape.44positional-cloning projects. It is less appropriate to use
some number of genes chosen at random, as was done to
test some othermethods,10 because of the tendency of sim-
ilar genes to cluster in chromosomal neighborhoods. For
instance, genes in the same metabolic pathway show sta-
tistically signiﬁcant genomic clustering as compared to
randomly chosen genes.34 Additionally, we found that pro-
teins coded by genes in the contiguous intervals around
disease genes are located in greater proximity to the corre-
sponding disease-gene family members in the PPI network
than are proteins coded by randomly chosen genes; com-
parison of mean shortest-path distance from genes other
than the disease gene within the 100-gene artiﬁcial inter-
val with the corresponding mean distance among 100 ran-
domly chosen genes showed a small but highly signiﬁcant
difference: 3.46 for the ’’interval genes’’ and 3.58 for the
randomly chosen genes, corresponding to a p value of
2.2 3 1016 (data not shown).
Another important issue lies in the deﬁnition of the
disease-gene families. In this work, we have deﬁned 110
disease-gene families by using both the OMIM database1
and domain knowledge (D.H., P.N.R.) (see Table S1). We
claim that this is the largest publicly available list of
disease-gene families available for the testing of gene-prior-
itization methods. Also important is the range of disease-
gene families and of genes for which a given method is ap-
plicable. In general, methods based on sequence analysis13
have no restrictions. Methods based on functional annota-
tion5–12 have no restrictions but will presumably function
poorly for novel disease genes for which little or no func-Thetional annotations are available. Especially as more pro-
tein-protein interaction data becomes available, we expect
that methods using this type of data will become evermore
accurate in their prediction of novel disease genes. Some of
these methods are limited to genes having direct interac-
tions with other known disease genes.17,33 Our method
can only be used for genes for which protein-protein inter-
actions are known or predicted, but it does not require
direct interactions. Thus, with our method, no prediction
was possible for 15 of the 783 genes tested. Many dis-
ease-gene families as currently deﬁned contain but two
or three members (see Table S1). Our method was tested
with families as small as three members, meaning that
two genes at a time were used as positive examples. Other
published methods have been tested with the use of larger
families (for instance, ENDEAVOUR10 was tested with fam-
ilies of eight or more genes), so it is unclear how these
methods will perform for smaller disease-gene families.
Therefore, we claim that we have used a realistic and bi-
ologically relevant testing strategy to measure the perfor-
mance of our methods.We have shown that the two global
distance measurements (RWR, DK) clearly outperform two
local network-search methods (DI, SP) and the sequence-
basedmethod PROSPECTR.13 Additionally, we used a panel
of recently identiﬁed monogenic disease genes to compare
RWR with both the local network search methods and
PROSPECTR, as well as with ENDEAVOUR.10 We expect
the inﬂuence of publication of functional data concerning
these new disease genes to be minimal, because their dis-
covery was published subsequent to the version of theAmerican Journal of Human Genetics 82, 949–958, April 2008 955
Figure 5. Stickler Syndrome Protein-Interaction Network
The protein-interaction network associated with Stickler syndrome comprises the genes COL2A1, COL9A1, COL11A1, and COL11A2. There is
no direct path between any pair of disease genes. Therefore, the DI method will not make any correct prediction. A number of false pre-
dictions of the SP method are shown in yellow. Most of these genes have a large number of direct interactions with other proteins, so that
the weight of any single interaction is small in the RWR and DK methods. Each of them has a single path of length 2 with one of the true
disease genes. In contrast, the true disease genes each have multiple paths of length 2 with other disease genes and therefore receive
a correspondly high score from the RWR and DK methods. For instance, the genes COL11A1, COL11A2, and COL2A1 are connected to one
another by 14 other genes. The graphic was generated as in Figure 4.STRING database we used. Although no single method was
superior for all of the genes tested, our RWR method out-
performed all other methods on average (Table 2).
It has recently become clear that networks pervade all
aspects of human health and that a network approach to
the analysis of cellular functions affected by genes and
gene products, rather than just a list of ’’disease genes,’’
will be necessary for the understanding of disease mecha-
nisms35 and that proteins mutated in phenotypically sim-
ilar diseases might form highly interlinked subnetworks
within the larger protein interaction network.36 In this
work, we have shown that network algorithms that mea-956 The American Journal of Human Genetics 82, 949–958, April 20sure not only direct and shortest-path interactions but
also take the global structure of the interactome into
account have a clear performance advantage in the priori-
tization of candidate disease genes. We suggest that this
supports the assumption that phenotypically similar dis-
eases are associated with disturbances of subnetworks
within the protein interactome and that exploration of
global network structures with appropriate graph-theoretic
algorithms will become an important resource for under-
standing of the biology of disease.
We have developed GeneWanderer, a freely available im-
plementation of all four network algorithms. Scientists08
involved in positional-cloning projects can search for
novel genes related to one of the 110 disease-gene families
described here or can provide their own disease-gene fam-
ily. They can then use our algorithm to rank genes in a link-
age interval in order to prioritize candidate genes for
sequencing. Many of the 110 disease-gene families ana-
lyzed in this work also contain loci with currently uniden-
tiﬁed genes. On the GeneWanderer homepage, we provide
predictions for 287 such loci from 80 disease-gene families
extracted from the Morbid Map of OMIM.1
Supplemental Data
Supplemental Data include two tables and can be found online at
http://www.ajhg.org/.
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